Quantum-Si Incorporated, a proteomics technology company, has announced a $50 million registered direct offering of common stock. The company has entered into a securities purchase agreement with a single institutional investor for the sale of 29,940,119 shares of common stock at a price of $1.67 per share. The offering is expected to close around July 8, 2025, pending customary closing conditions. A.G.P./Alliance Global Partners is serving as the sole placement agent for the transaction. The proceeds from this offering are intended for working capital and general corporate purposes.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。